Ilyang Pharmaceutical

일양약품 · 007570

Health Care Pharmaceuticals · KOSPI

Small-cap

Market cap US$115.1M (₩158.8B)

Overview

Ilyang Pharmaceutical makes prescription and over-the-counter medicines supplied to hospitals, clinics, and pharmacies in Korea.

The company is listed on KOSPI, Korea's main stock exchange, and operates across the broader pharmaceutical industry serving healthcare providers and patients. Because the filing text does not detail a single dominant product line or structural shift, the business is best described as a diversified domestic pharmaceutical company.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$197.4M

▲ +1.3% YoY

Operating profit · FY2025

US$3.6M

▼ −54.9% YoY

Net income · FY2025

US$5.2M

▼ −32.1% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$193.2M(₩266.7B)	US$194.8M(₩268.9B)	US$197.4M(₩272.4B)
Operating profit	US$11.9M(₩16.4B)	US$8M(₩11B)	US$3.6M(₩5B)
Net income	−US$1.5M(−₩2B)	US$7.6M(₩10.5B)	US$5.2M(₩7.1B)

Revenue

FY2023US$193.2M
FY2024US$194.8M
FY2025US$197.4M

Operating profit

FY2023US$11.9M
FY2024US$8M
FY2025US$3.6M

Net income

FY2023−US$1.5M
FY2024US$7.6M
FY2025US$5.2M

Key ratios (FY2025)

ROE

3.0%

Debt/Eq

89.4%

Op. margin

1.8%

Net margin

2.6%

Rev. YoY

▲ +1.3%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?